SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Read More…
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorMedical
Phone928-779-4143
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$300,000.00
Profitability
Miscellaneous
Employees40
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable
SenesTech (NASDAQ:SNES) Frequently Asked Questions
What is SenesTech's stock symbol?
SenesTech trades on the NASDAQ under the ticker symbol "SNES."
How were SenesTech's earnings last quarter?
SenesTech Inc (NASDAQ:SNES) posted its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The business earned $0.02 million during the quarter. SenesTech had a negative return on equity of 152.75% and a negative net margin of 3,432.63%. View SenesTech's Earnings History.
When is SenesTech's next earnings date?
Has SenesTech been receiving favorable news coverage?
News stories about SNES stock have been trending negative this week, InfoTrie reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. SenesTech earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for SenesTech.
Who are some of SenesTech's key competitors?
What other stocks do shareholders of SenesTech own?
Who are SenesTech's key executives?
SenesTech's management team includes the folowing people:
- Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 70)
- Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 67)
- Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 60)
- Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 64)
- Mr. Joe Malinowski, VP of Sales
When did SenesTech IPO?
(SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.
Who are SenesTech's major shareholders?
SenesTech's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (1.13%), BlackRock Inc. (0.23%), Bank of New York Mellon Corp (0.12%), MRA Associates USA LLC (0.09%) and First Interstate Bank (0.06%). Company insiders that own SenesTech stock include Andrew Altman, Cheryl Ann Dyer, Julia Ann Williams, Kenneth S Siegel and Loretta Powers Mayer. View Institutional Ownership Trends for SenesTech.
Which institutional investors are buying SenesTech stock?
SNES stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., Bank of New York Mellon Corp, MRA Associates USA LLC and First Interstate Bank. Company insiders that have bought SenesTech stock in the last two years include Andrew Altman, Julia Ann Williams and Kenneth S Siegel. View Insider Buying and Selling for SenesTech.
How do I buy shares of SenesTech?
Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SenesTech's stock price today?
One share of SNES stock can currently be purchased for approximately $1.37.
How big of a company is SenesTech?
SenesTech has a market capitalization of $38.76 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe.View Additional Information About SenesTech.
What is SenesTech's official website?
How can I contact SenesTech?
SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]
MarketBeat Community Rating for SenesTech (NASDAQ SNES)
MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days.
